Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Fu-Shi Quan, Swarnendu Basak, Ki-Back Chu, Sung Soo Kim & Sang-Moo Kang. (2020) Progress in the development of virus-like particle vaccines against respiratory viruses. Expert Review of Vaccines 19:1, pages 11-24.
Read now
Read now
Laurent Durous, Manuel Rosa-Calatrava & Emma Petiot. (2019) Advances in influenza virus-like particles bioprocesses. Expert Review of Vaccines 18:12, pages 1285-1300.
Read now
Read now
Eun-Kyung Moon, Hae-Ji Kang, Ki-Back Chu, Su-Hwa Lee, Dong-Hun Lee, Yunsoo Soh & Fu-Shi Quan. (2019) Immune Correlates of Protection Induced by Virus-Like Particles Containing 2009 H1N1 Pandemic Influenza HA, NA or M1 Proteins. Immunological Investigations 48:4, pages 355-366.
Read now
Read now
Articles from other publishers (40)
Masoumeh Firouzamandi, Javad Ashrafi Helan, Hassan Moeini, Alireza Soleimanian, Saeed Khatemeh & Seyed Davoud Hosseini. (2023) Developing a vaccine against velogenic sub-genotype seven of Newcastle disease virus based on virus-like particles. AMB Express 13:1.
Crossref
Crossref
Zhanzhuo Mai, Mengkai Cai, Xiaokun Hu, Meidi Li, Yikuan Ji, Shaofang Li, Junmei Huang, Quanming Liang, Chihai Ji, Heyou Yi, Guihong Zhang & Lang Gong. (2023) Protection efficacy of the H1 and H3 bivalent virus-like particle vaccine against swine influenza virus infection. Veterinary Microbiology 280, pages 109719.
Crossref
Crossref
Yi-xue Sun, Zheng-rong Li, Peng-ju Zhang, Jin-hong Han, Hai-yang Di, Jia-yi Qin & Yan-long Cong. (2022) A Single Vaccination of Chimeric Bivalent Virus-Like Particle Vaccine Confers Protection Against H9N2 and H3N2 Avian Influenza in Commercial Broilers and Allows a Strategy of Differentiating Infected from Vaccinated Animals. Frontiers in Immunology 13.
Crossref
Crossref
Andrea Briones, Gustavo Martos, Magali Bedu, Tiphaine Choteau, Ralf D. Josephs, Robert I. Wielgosz & Maxim G. Ryadnov. (2022) An SI-traceable reference material for virus-like particles. iScience 25:5, pages 104294.
Crossref
Crossref
Stephen R. Welch, Jessica R. Spengler, Jessica R. Harmon, JoAnn D. Coleman-McCray, Florine E. M. Scholte, Sarah C. Genzer, Michael K. Lo, Joel M. Montgomery, Stuart T. Nichol & Christina F. Spiropoulou. (2022) Defective Interfering Viral Particle Treatment Reduces Clinical Signs and Protects Hamsters from Lethal Nipah Virus Disease. mBio 13:2.
Crossref
Crossref
Mengkai Cai, Ping Gan, Xiaokun Hu, Zhanzhuo Mai, Chihai Ji, Heyou Yi, Meidi Li, Shaofang Li, Yikuan Ji, Junmei Huang, Guihong Zhang & Lang Gong. (2022) Protective effect of bivalent H1N1 and H3N2 VLP vaccines against Eurasian avian-like H1N1 and recent human-like H3N2 influenza viruses in a mouse model. Veterinary Microbiology 266, pages 109370.
Crossref
Crossref
Hasnat Tariq, Sannia Batool, Saaim Asif, Mohammad Ali & Bilal Haider Abbasi. (2022) Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases. Frontiers in Microbiology 12.
Crossref
Crossref
Jiao Hu, Qi Zhang, Peipei Peng, Rumeng Li, Jun Li, Xiaoquan Wang, Min Gu, Zenglei Hu, Shunlin Hu, Xiaowen Liu, Mei Mei, Xinan Jiao, Daxin Peng & Xiufan Liu. (2022) Baculovirus-derived influenza virus-like particle confers complete protection against lethal H7N9 avian influenza virus challenge in chickens and mice. Veterinary Microbiology 264, pages 109306.
Crossref
Crossref
Vili Lampinen, Suvi Heinimäki, Olli H. Laitinen, Marko Pesu, Minna M. Hankaniemi, Vesna Blazevic & Vesa P. Hytönen. (2021) Modular vaccine platform based on the norovirus-like particle. Journal of Nanobiotechnology 19:1.
Crossref
Crossref
Jiao Hu, Peipei Peng, Jun Li, Qi Zhang, Rumeng Li, Xiaoquan Wang, Min Gu, Zenglei Hu, Shunlin Hu, Xiaowen Liu, Xinan Jiao, Daxin Peng & Xiufan Liu. (2021) Single Dose of Bivalent H5 and H7 Influenza Virus-Like Particle Protects Chickens Against Highly Pathogenic H5N1 and H7N9 Avian Influenza Viruses. Frontiers in Veterinary Science 8.
Crossref
Crossref
Sofia B. Carvalho, Cristina Peixoto, Manuel J. T. Carrondo & Ricardo J. S. Silva. (2021) Downstream processing for influenza vaccines and candidates: An update. Biotechnology and Bioengineering 118:8, pages 2845-2869.
Crossref
Crossref
Jun Li, Rumeng Li, Qi Zhang, Peipei Peng, Xiaoquan Wang, Min Gu, Zenglei Hu, Xinan Jiao, Daxin Peng, Jiao Hu & Xiufan Liu. (2021) H7N9 influenza virus-like particle based on BEVS protects chickens from lethal challenge with highly pathogenic H7N9 avian influenza virus. Veterinary Microbiology 258, pages 109106.
Crossref
Crossref
S. V. Chepur, N. N. Pluzhnikov, O. V. Chubar, L. S. Bakulina, I. V. Litvinenko, V. A. Makarov, A. S. Gogolevsky, V. A. Myasnikov, I. A. Myasnikova & R. I. Al-Shehadat. (2021) Respiratory RNA Viruses: How to Be Prepared for an Encounter with New Pandemic Virus Strains. Biology Bulletin Reviews 11:2, pages 154-171.
Crossref
Crossref
Swarnendu Basak, Hae-Ji Kang, Ki-Back Chu, Judy Oh & Fu-Shi Quan. (2021) Simple and rapid plaque assay for recombinant baculoviruses expressing influenza hemagglutinin. Science Progress 104:1, pages 003685042110042.
Crossref
Crossref
Jingdi Pan & Zongqiang Cui. (2020) Self‐Assembled Nanoparticles: Exciting Platforms for Vaccination. Biotechnology Journal 15:12, pages 2000087.
Crossref
Crossref
Vadim Makarov, Olga Riabova, Sean Ekins, Nikolay Pluzhnikov & Sergei Chepur. (2020) The past, present and future of RNA respiratory viruses: influenza and coronaviruses. Pathogens and Disease 78:7.
Crossref
Crossref
Wen-Hung Wang, Esmeralda Merari Erazo, Max R. Chang Ishcol, Chih-Yen Lin, Wanchai Assavalapsakul, Arunee Thitithanyanont & Sheng-Fan Wang. (2019) Virus-induced pathogenesis, vaccine development, and diagnosis of novel H7N9 avian influenza A virus in humans: a systemic literature review. Journal of International Medical Research 48:1, pages 030006051984548.
Crossref
Crossref
Miao Li, Yi Wang, Yuan Sun, Hongyu Cui, Shu J. Zhu & Hua-Ji Qiu. (2020) Mucosal vaccines: Strategies and challenges. Immunology Letters 217, pages 116-125.
Crossref
Crossref
Chia-Chun Lai, Yu-Chieh Cheng, Pin-Wen Chen, Ting-Hui Lin, Tsai-Teng Tzeng, Chia-Chun Lu, Min-Shi Lee & Alan Yung-Chih Hu. (2019) Process development for pandemic influenza VLP vaccine production using a baculovirus expression system. Journal of Biological Engineering 13:1.
Crossref
Crossref
Andrew J. Zak, Brett D. Hill, Syed M. Rizvi, Mason R. Smith, Madeleine Yang & Fei Wen. (2019) Enhancing the Yield and Quality of Influenza Virus-like Particles (VLPs) Produced in Insect Cells by Inhibiting Cytopathic Effects of Matrix Protein M2. ACS Synthetic Biology 8:10, pages 2303-2314.
Crossref
Crossref
Mandy Gebauer, Hans C. Hürlimann, Martina Behrens, Thorsten Wolff & Sven-Erik Behrens. (2019) Subunit vaccines based on recombinant yeast protect against influenza A virus in a one-shot vaccination scheme. Vaccine 37:37, pages 5578-5587.
Crossref
Crossref
Cynthia Calzas & Christophe Chevalier. (2019) Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections. Frontiers in Immunology 10.
Crossref
Crossref
Hae-Ji Kang, Su-Hwa Lee, Min-Ju Kim, Ki-Back Chu, Dong-Hun Lee, Manika Chopra, Hyo-Jick Choi, Hyunwoo Park, Hui Jin & Fu-Shi Quan. (2019) Influenza Virus-Like Particles Presenting both Toxoplasma gondii ROP4 and ROP13 Enhance Protection against T. gondii Infection. Pharmaceutics 11:7, pages 342.
Crossref
Crossref
Sofia B. Carvalho, Ricardo J.S. Silva, Ana Sofia Moreira, Bárbara Cunha, João J. Clemente, Paula M. Alves, Manuel J.T. Carrondo, Alex Xenopoulos & Cristina Peixoto. (2019) Efficient filtration strategies for the clarification of influenza virus-like particles derived from insect cells. Separation and Purification Technology 218, pages 81-88.
Crossref
Crossref
Kapil Gupta, Christine Tölzer, Duygu Sari-Ak, Daniel Fitzgerald, Christiane Schaffitzel & Imre Berger. (2019) MultiBac: Baculovirus-Mediated Multigene DNA Cargo Delivery in Insect and Mammalian Cells. Viruses 11:3, pages 198.
Crossref
Crossref
Su-Hwa Lee, Hae-Ji Kang, Dong-Hun Lee & Fu-Shi Quan. (2019) Protective Immunity Induced by Incorporating Multiple Antigenic Proteins of Toxoplasma gondii Into Influenza Virus-Like Particles. Frontiers in Immunology 9.
Crossref
Crossref
Thomas N. Vilches, Majid Jaberi-Douraki & Seyed M. Moghadas. (2019) Risk of influenza infection with low vaccine effectiveness: the role of avoidance behaviour. Epidemiology and Infection 147.
Crossref
Crossref
Lev A. Dykman, Sergey A. Staroverov & Alexander S. Fomin. (2018) Effect of M2e peptide–gold nanoparticle conjugates on development of anti-influenza antibodies. Gold Bulletin 51:4, pages 197-203.
Crossref
Crossref
Emmanuel Margolin, Ros Chapman, Anna-Lise Williamson, Edward P. Rybicki & Ann E. Meyers. (2018) Production of complex viral glycoproteins in plants as vaccine immunogens. Plant Biotechnology Journal 16:9, pages 1531-1545.
Crossref
Crossref
Sofia B Carvalho, A Raquel Fortuna, Michael W Wolff, Cristina Peixoto, Paula M Alves, Udo Reichl & Manuel JT Carrondo. (2018) Purification of influenza virus-like particles using sulfated cellulose membrane adsorbers. Journal of Chemical Technology & Biotechnology 93:7, pages 1988-1996.
Crossref
Crossref
Norbert Pardi, Michael J. Hogan, Martin S. Naradikian, Kaela Parkhouse, Derek W. Cain, Letitia Jones, M. Anthony Moody, Hans P. Verkerke, Arpita Myles, Elinor Willis, Celia C. LaBranche, David C. Montefiori, Jenna L. Lobby, Kevin O. Saunders, Hua-Xin Liao, Bette T. Korber, Laura L. Sutherland, Richard M. Scearce, Peter T. Hraber, István Tombácz, Hiromi Muramatsu, Houping Ni, Daniel A. Balikov, Charles Li, Barbara L. Mui, Ying K. Tam, Florian Krammer, Katalin Karikó, Patricia Polacino, Laurence C. Eisenlohr, Thomas D. Madden, Michael J. Hope, Mark G. Lewis, Kelly K. Lee, Shiu-Lok Hu, Scott E. Hensley, Michael P. Cancro, Barton F. Haynes & Drew Weissman. (2018) Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. Journal of Experimental Medicine 215:6, pages 1571-1588.
Crossref
Crossref
Alfred Harding & Nicholas Heaton. (2018) Efforts to Improve the Seasonal Influenza Vaccine. Vaccines 6:2, pages 19.
Crossref
Crossref
Kangwei Xu, Changgui Li, Caroline Gravel, Zheng Jiang, Bozena Jaentschke, Gary Van Domselaar, Xuguang Li & Junzhi Wang. (2018) Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines. Scientific Reports 8:1.
Crossref
Crossref
Ah-Ra Kim, Dong-Hun Lee, Su-Hwa Lee, Ilaria Rubino, Hyo-Jick Choi & Fu-Shi Quan. (2018) Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein. PLOS ONE 13:1, pages e0191277.
Crossref
Crossref
Luis Martinez-Gil, Peter H. Goff & Gene S. Tan. 2018.
1
37
.
Dong-Hun Lee, Ah-Ra Kim, Su-Hwa Lee & Fu-Shi Quan. (2017) Virus-like particles vaccine containing Clonorchis sinensis tegumental protein induces partial protection against Clonorchis sinensis infection. Parasites & Vectors 10:1.
Crossref
Crossref
Gale E. Smith, Xiangjie Sun, Yaohui Bai, Ye V. Liu, Michael J. Massare, Melissa B. Pearce, Jessica A. Belser, Taronna R. Maines, Hannah M. Creager, Gregory M. Glenn, David Flyer, Peter Pushko, Min Z. Levine & Terrence M. Tumpey. (2017) Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets. Virology 509, pages 90-97.
Crossref
Crossref
Alexander I. Makarkov, Sabrina Chierzi, Stéphane Pillet, Keith K. Murai, Nathalie Landry & Brian J. Ward. (2017) Plant-made virus-like particles bearing influenza hemagglutinin (HA) recapitulate early interactions of native influenza virions with human monocytes/macrophages. Vaccine 35:35, pages 4629-4636.
Crossref
Crossref
Sofia B. Carvalho, Mafalda G. Moleirinho, David Wheatley, John Welsh, René Gantier, Paula M. Alves, Cristina Peixoto & Manuel J. T. Carrondo. (2017) Universal label-free in-process quantification of influenza virus-like particles. Biotechnology Journal 12:8, pages 1700031.
Crossref
Crossref
Lisa H. Tostanoski & Christopher M. Jewell. (2017) Engineering self-assembled materials to study and direct immune function. Advanced Drug Delivery Reviews 114, pages 60-78.
Crossref
Crossref